{Reference Type}: Journal Article
{Title}: Hereditary angioedema classification: Expanding knowledge by genotyping and endotyping.
{Author}: Giavina-Bianchi P;Vivolo Aun M;Giavina-Bianchi M;Ribeiro AJ;Camara Agondi R;Motta AA;Kalil J;
{Journal}: World Allergy Organ J
{Volume}: 17
{Issue}: 5
{Year}: 2024 May
{Factor}: 5.516
{DOI}: 10.1016/j.waojou.2024.100906
{Abstract}: Hereditary angioedema (HAE) encompasses a group of diseases characterized by recurrent, genetically mediated angioedema associated with increased vascular permeability primarily due to bradykinin. The disease poses diagnostic challenges, leading to underdiagnosis and delayed therapy. Severe manifestations include laryngeal and intestinal angioedema, contributing to significant morbidity and mortality. If left undiagnosed, the estimated mortality rate of the disease ranges from 25% to 40% due to asphyxiation caused by laryngeal angioedema. There is a pressing need to enhance awareness of hereditary angioedema and its warning signs. The acronym "H4AE" may facilitate the memorization of these signs. This study comprehensively reviews clinical, laboratory, and physiopathological features of documented HAE subtypes. The study advocates for an improved HAE classification based on endotypes, building on the knowledge of angioedema pathophysiology. The proposed endotype classification of HAE offers a clear and applicable framework, encouraging advancements in disease understanding and classification.